Trade Summary

Yesterday, Rote William E., serving as Chief Research Officer at Travere Therapeutics, Inc. (TVTX), sold 2,763 shares at $43.95 per share, for a total transaction value of $121,434.00. Following this transaction, Rote William E. now holds 115,474 shares of TVTX.

This sale represents a 2.00% decrease in Rote William E.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, meaning the disclosure happened on the same day as the trade.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.